Sol J. Barer - 04 Apr 2023 Form 4 Insider Report for NexImmune, Inc.

Role
Director
Signature
/s/ John Rudy, attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
04 Apr 2023
Net transactions value
$0
Form type
4
Filing time
06 Apr 2023, 20:34:44 UTC
Previous filing
31 Mar 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Disposed to Issuer -61,678 -100% 0 04 Apr 2023 Common Stock 61,678 $1.82 Direct F1
transaction NEXI Stock Option (right to buy) Award +61,678 61,678 04 Apr 2023 Common Stock 61,678 $1.64 Direct F1
transaction NEXI Stock Option (right to buy) Disposed to Issuer -19,113 -100% 0 04 Apr 2023 Common Stock 19,113 $17.00 Direct F2
transaction NEXI Stock Option (right to buy) Award +19,113 19,113 04 Apr 2023 Common Stock 19,113 $1.64 Direct F2
transaction NEXI Stock Option (right to buy) Disposed to Issuer -155,900 -100% 0 04 Apr 2023 Common Stock 155,900 $5.17 Direct F3
transaction NEXI Stock Option (right to buy) Award +155,900 155,900 04 Apr 2023 Common Stock 155,900 $1.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date.
F2 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested.
F3 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option.